HPLC column NUCLEODUR ® C 8 Gravity, 5 µm, 100 mm, 4 mm
Order number: 344L.1
Part number: AC100008886
£ 628.88*
*Prices without VAT and shipping costs£ 754.66*
*incl. VAT, plus shipping costsPrice Breakdown
1
6
24
Built to deliver predictable results in synthesis routines, the HPLC column NUCLEODUR® C 8 Gravity, 5 μm, 100 mm, 4 mm offers exceptional performance for reversed phase separations. Its high density C 8 phase based on high purity NUCLEODUR® silica gel ensures reduced polar interactions, making it ideal for the separation of basic and other ionizable analytes. With an enhanced pH stability range of 1.0-11.0, this column is LC/MS compatible and exhibits superior base deactivation, making it a valuable tool for RP applications and method development. The column's particle size of 5 μm provides excellent efficiency and resolution, while its pressure stability of up to 600 bar allows for robust operation under various conditions. Recommended applications include but are not limited to pharmaceuticals, antidepress
- Category: Separation columns for HPLC
- Pressure stability: 600 bar
- Column volume: 1.25 ml
- Eluent in column: Acetonitrile - Water
- Phase: C 8 Gravity
- Pore volume: 0.9 ml/g
- Temperature stability: 60 ° C
- pH stability: 1,0-11,0
- Surface chemistry: Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification
- Similar phases: NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8
- Column type: HPLC column
- Particle size: 5 µm
- Pore size: 110 Å
- Column shape: Analytical separation column
- USP listing: L7
- Particle type: Fully porous particles (FPP)
- Endcapped: yes
- Recommended application(s): In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals
- Interactions / retention mechanism: hydrophobic (van der Waals)
- Specific surface according to BET: 340 m²/g
- Separation principle: Reversed phase (RP)
- L x Ø internal (column): 100 x 4 mm
| Name | Value | |
|---|---|---|
| Phase | : | C 8 Gravity |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | HPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L7 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-11,0 |
| Column volume | : | 1.25 ml |
| Particle size | : | 5 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8 |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification |
| Pressure stability | : | 600 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 100 x 4 mm |
| Recommended application(s) | : | In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic (van der Waals) |
